Cephalon, Inc.
Records under this name other than the patents Cephalon, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 57 patents it holds.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,576,206 | Proteasome Inhibitors and Methods of Using the Same Formerly held In force · High confidence | In force | High confidence | |
| US 8,673,916 | Methods of treating disorders mediated by histamine H3 receptors using pyridazinone derivatives Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,207,168 | Pyridazinone derivatives Formerly held In force (reinstated) · From the USPTO record | In force (reinstated) | From the USPTO record | |
| US 8,586,588 | Aryl pyridazinone derivatives and their use as H3 receptor ligands Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,318,699 | Tumor Necrosis Factor Inhibitors Formerly held In force · High confidence | In force | High confidence | |
| US 8,071,604 | Thio-Substituted Arylmethanesulfinyl Derivatives Formerly held In force · High confidence | In force | High confidence | |
| US 8,148,391 | Fused bicyclic derivatives of 2,4-diaminopyrimidine as ALK and c-Met inhibitors Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,247,414 | Pyridizinone derivatives and the use thereof as H3 inhibitors Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,524,713 | Substituted spirocyclic piperidine derivatives as histamine-3 (H3) receptor ligands Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,884,014 | Method for purifying a fused pyrrolocarbazole derivative Formerly held In force · From the USPTO record | In force | From the USPTO record |